Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
American Journal of Clinical Oncology
|
June 1, 2005
Evaluating risk factors for the development of ifosfamide encephalopathy
Kevin A David, Joel Picus
Current Hematologic Malignancy Reports
|
February 24, 2017
Clinical Studies in Hematologic Microtransplantation
Kevin A David, Dennis Cooper, Roger Strair
The Lancet. Haematology
|
April 14, 2018
Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?
Kevin A David, Athena Kritharis, Andrew M Evens
Current Treatment Options in Oncology
|
January 25, 2008
Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options
Kevin A David, Lauren Mauro, Andrew M Evens
Clinical Genitourinary Cancer
|
May 30, 2006
Chemotherapy for non-clear-cell renal cell carcinoma
Kevin A David, Matthew I Milowsky, David M Nanus
Current Treatment Options in Oncology
|
April 25, 2020
Current Treatment Options for Older Patients with Hodgkin Lymphoma
Jordan Carter, Kevin A David, Athena Kritharis, et al.
Hematology. American Society of Hematology. Education Program
|
December 7, 2019
Management of older Hodgkin lymphoma patients
Andrew M Evens, Jordan Carter, Kah Poh Loh, et al.
Current Oncology Reports
|
August 18, 2020
Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches
Mansi R Shah, Justin S Brandt, Kevin A David, et al.
The Journal of Urology
|
June 15, 2007
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base
Kevin A David, Matthew I Milowsky, Jamie Ritchey, et al.
The Journal of Urology
|
March 23, 2011
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)
Katherine Mallin, Kevin A David, Peter R Carroll, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
American Journal of Clinical Oncology
|
June 1, 2005
Evaluating risk factors for the development of ifosfamide encephalopathy
Kevin A David, Joel Picus
Current Hematologic Malignancy Reports
|
February 24, 2017
Clinical Studies in Hematologic Microtransplantation
Kevin A David, Dennis Cooper, Roger Strair
The Lancet. Haematology
|
April 14, 2018
Does Q fever contribute to pathogenesis of non-Hodgkin lymphoma?
Kevin A David, Athena Kritharis, Andrew M Evens
Current Treatment Options in Oncology
|
January 25, 2008
Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options
Kevin A David, Lauren Mauro, Andrew M Evens
Clinical Genitourinary Cancer
|
May 30, 2006
Chemotherapy for non-clear-cell renal cell carcinoma
Kevin A David, Matthew I Milowsky, David M Nanus
Current Treatment Options in Oncology
|
April 25, 2020
Current Treatment Options for Older Patients with Hodgkin Lymphoma
Jordan Carter, Kevin A David, Athena Kritharis, et al.
Hematology. American Society of Hematology. Education Program
|
December 7, 2019
Management of older Hodgkin lymphoma patients
Andrew M Evens, Jordan Carter, Kah Poh Loh, et al.
Current Oncology Reports
|
August 18, 2020
Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches
Mansi R Shah, Justin S Brandt, Kevin A David, et al.
The Journal of Urology
|
June 15, 2007
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base
Kevin A David, Matthew I Milowsky, Jamie Ritchey, et al.
The Journal of Urology
|
March 23, 2011
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)
Katherine Mallin, Kevin A David, Peter R Carroll, et al.
Page
of 4